Keywords: first, patients, enrolled, teva, adagio, study, israeli

First patients enrolled in Teva's ADAGIO study

Article | 19 December 2005

Print This

Israeli drugmaker Teva says that patient recruitment has begun in a landmark study that will evaluate whether its drug Agilect/ ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in